Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
Lianne ParkinSheila WilliamsDavid BarsonKatrina SharplesSimon HorsburghRod JacksonJack DummerPublished in: BMJ open respiratory research (2021)
In real-world clinical practice, use of two versus one long-acting bronchodilator by people with COPD is associated with a higher risk of ACS.